Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #PPRNET28

NSAID or Cox 2 Inhibitor Use in Patients with Heart Failure (HF) or Chronic Kidney Disease (CKD)

The percentage of adult patients with HF, HTN or CKD who are not prescribed an NSAID or COX 2 inhibitor. The CQM is aligned with a 2015 FDA Drug Safety Communication and corresponding NSAID label changes: “the risk of heart attack or stroke can occur as early as the first weeks.” Evidence from observational studies suggest that high risk patients (i.e. those eligible for the CQM) are at highest risk of harm in the first month of exposure.

Submission Methods: Registry

There are no codes for this QPP measure.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.